Proxy Votes Now

Home › Funds › Capital Group › Capital Group U.S. Large Value ETF

Capital Group U.S. Large Value ETF (CGVV) proxy voting record 2025-2026

Fund family: Capital Group · Filed by Capital Group Equity ETF Trust I (CIK 2034928) · SEC series S000092696

Ticker: CGVV (C000260731)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 770 with, 67 against, 1 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 21 FOR, 47 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Capital Group as a whole

The same two figures as Capital Group’s manager page (120,065 ballot items across 80 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsCapital GroupItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)98.8%75296.6%98,284
Backed environmental and social shareholder proposals at US companiesn/a371.3%2,130

Where this fund voted differently from most Capital Group funds

Each ballot item this fund voted is set against the votes of the other Capital Group funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Capital Group funds on 4 items (0.5% of the 738 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Capital Group fundsMgmtResult
Affirm Holdings, Inc.2025-12-15To approve, on a non-binding advisory basis, the compensation of our named executive officers.ForAGAINST — 8 of 8 Capital Group fundsForApproved, 96.8% support
UnitedHealth Group Incorporated2026-06-01Shareholder If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent.ForAGAINST — 15 of 22 Capital Group fundsAgainstNot approved, 20.3% support
Starbucks Corporation2026-03-25Election of Directors: Andy CampionAgainstFOR — 13 of 21 Capital Group fundsAgainstElected, 87.3% support
Berkshire Hathaway Inc.2026-05-02Shareholder Shareholder proposal requesting that the Company issue a report disclosing the Board's oversight framework for workforce and human-capital management across its operating subsidiaries.ForAGAINST — 4 of 7 Capital Group fundsAgainst—

Download all 4 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 838 such votes could be given a sector.

SectorVotesAgainst managementShare
Technology1622616.0%
Finance161127.5%
Consumer Discretionary12697.1%
Industrials12154.1%
Health Care4936.1%
Telecommunications4848.3%
Utilities48510.4%
Energy4624.3%
Basic Materials3800.0%
Consumer Staples1715.9%
Miscellaneous1300.0%
Real Estate900.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections6070
Say-on-Pay590
Audit-related580
Corporate Governance4426
Compensation242
Environment or Climate1919
Other Social Issues1313
Capital Structure80
Human Rights or Human Capital/workforce44
Extraordinary Transactions30

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Amazon.com, Inc.May 20, 2026$6M174
Meta Platforms, Inc.May 27, 2026$5M229
GE Healthcare Technologies, Inc.May 7, 2026$4M100
Berkshire Hathaway Inc.May 2, 2026$4M161
APi Group CorporationMay 15, 2026$3M120
Vertex Pharmaceuticals IncorporatedMay 13, 2026$3M141
Intel CorporationMay 13, 2026$3M183
JPMorgan Chase & Co.May 19, 2026$3M174

Notable votes against management

MeetingCompanyProposalFundMgmt
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on Al data usage oversight. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 2, 2026Berkshire Hathaway Inc.Shareholder proposal requesting that the Company issue a report disclosing the Board's oversight framework for workforce and human-capital management across its operating subsidiaries. Shareholder proposalForAgainst
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalForAgainst
May 13, 2026Intel CorporationStockholder proposal requesting a report on risk of China exposure. Shareholder proposalAgainstFor
May 13, 2026Intel CorporationStockholder proposal requesting a report on Intel's human rights due diligence process. Shareholder proposalAgainstFor
May 19, 2026JPMorgan Chase & Co.Report on congruence of security, resiliency, and climate initiatives Shareholder proposalAgainstFor
May 19, 2026JPMorgan Chase & Co.Independent board chairman Shareholder proposalAgainstFor
May 27, 2026Exxon Mobil CorporationIndependent Chair, a proposal overwhelmingly defeated on 16 separate occasions since 2000 Shareholder proposalForAgainst
May 27, 2026Exxon Mobil CorporationProposal requesting Company to modify its Voluntary Retail Voting Program to provide multiple options not aligned with the Board's recommendations Shareholder proposalForAgainst

Search this fund’s votes by company

842 ballot items at 60 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Capital Group U.S. Large Value ETF (CGVV) voted at 60 shareholder meetings of 59 companies, on 842 ballot items in all. Where management made a recommendation, the fund followed it on 91.9% of the items and voted against it 67 times. Its most frequent area of disagreement was corporate governance (26 of its votes against management). It voted FOR 30.9% of the 68 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Capital Group's funds as a whole (98.8% against 96.6%). It voted differently from most Capital Group funds on 4 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Capital Group’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.